Rationale for the Strong Response to Immunotherapy in Melanoma

November 17, 2018
Hussein A. Tawbi, MD, PhD

Hussein A. Tawbi, MD, PhD, discusses why melanoma responds so well to immunotherapy.

Hussein A. Tawbi, MD, PhD, director of Melanoma Clinical Research and Early Drug Development in the Department of Melanoma Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses why melanoma responds so well to immunotherapy.